Gulf International Bank (Uk) LTD Jazz Pharmaceuticals PLC Transaction History

Gulf International Bank (Uk) LTD

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Jan 11, 2024	SELL	$114.26 - $136.0 $67,413 - $80,240	-590 Reduced 10.05%	5,283 $649,000
Q3 2023 Oct 10, 2023	SELL	$122.0 - $145.31 $60,512 - $72,073	-496 Reduced 7.79%	5,873 $760,000
Q2 2023 Aug 02, 2023	SELL	$122.5 - $147.16 $232,382 - $279,162	-1,897 Reduced 22.95%	6,369 $789,000
Q1 2023 Apr 12, 2023	SELL	$133.98 - $160.47 $35,906 - $43,005	-268 Reduced 3.14%	8,266 $1.21 Million
Q4 2021 Jan 24, 2022	SELL	$119.87 - $145.67 $188,435 - $228,993	-1,572 Reduced 15.56%	8,534 $1.09 Million
Q1 2021 May 14, 2021	SELL	$150.19 - $173.5 $225,285 - $260,250	-1,500 Reduced 12.92%	10,106 $1.66 Million
Q4 2020 Feb 12, 2021	BUY	$140.71 - $165.05 $1.63 Million - $1.92 Million	11,606 New	11,606 $1.92 Million

512

57.5M

188K

133K

Ticker JAZZ
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 62,680,700
Market Cap $7.71B
Description
Jazz Pharmaceuticals plc, a biopharmaceutical company, identifies, develops, and commercializes pharmaceutical products for various unmet medical needs in the United States, Europe, and internationally. The company has a portfolio of products and product candidates with a focus in the areas of neuroscience, including sleep medicine and movement ...

Get notified when there are updates to the investment portfolio of Gulf International Bank (Uk) LTD, based on Form 13F filings with the SEC.

Stay updated on Gulf International Bank (Uk) LTD with notifications on news.